Shared and distinct gain-of-function consequences from pathologic cytoplasmic versus nuclear TDP-43
Open Access
- 11 August 2026
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Abstract
While predominantly nuclear localized in healthy cells, TDP-43 can transit between the nucleus and cytoplasm. In frontotemporal lobar degeneration (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), TDP-43 accumulates in hyperphosphorylated cytoplasmic aggregates. However, a subset of patients develops nuclear aggregates. Expression of wild-type TDP-43 in C. elegans neurons results in nuclear protein accumulation and toxic gain of function. To enable comparative study of nuclear and cytoplasmic TDP-43 phenotypes, we generated new models with inactivating mutations in the nuclear localization sequence (NLS) of TDP-43. When compared to nuclear TDP-43 strains, similar protein levels of cytoplasmic TDP-43 cause less neuronal dysfunction in C. elegans . Using RNA sequencing, we determine that transcriptomes are largely unchanged in these models. However, we identify innate immune pathway increases in response to cytoplasmic but not nuclear TDP-43. We find phosphorylation-mediated neurotoxicity of both cytoplasmic and nuclear localized TDP-43 is controlled by the phosphatase calcineurin. We also find that overexpression of the unfolded protein response (UPR) transcription factor XBP-1s worsens outcomes for wild-type TDP-43 animals but improves TDP-43 ΔNLS, suggesting different pathways controlling toxicity and clearance of nuclear versus cytoplasmic TDP-43. Taken together, these data support shared and distinct cellular responses to nuclear versus cytoplasmic TDP-43 localization in an intact animal nervous system. This comparative approach supports a better understanding of human disease and informs therapeutic development for pathological subtypes of TDP-43 proteinopathies.Keywords
Funding Information
- National Institutes of Health (R01AG066729)
- National Institutes of Health (F31AG082391)
- National Institutes of Health (R01NS064131)
- U.S. Department of Veterans Affairs (I01BX005762)
- U.S. Department of Veterans Affairs (IK6BX006467)
This publication has 72 references indexed in Scilit:
- TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosisBiochemical and Biophysical Research Communications, 2006
- Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral SclerosisScience, 2006
- Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegansHuman Molecular Genetics, 2006
- Expression Profiling of GABAergic Motor Neurons in Caenorhabditis elegansCurrent Biology, 2005
- Activity of protein phosphatase calcineurin is decreased in sporadic and familial amyotrophic lateral sclerosispatientsJournal of Neurochemistry, 2004
- The GABA nervous system in C. elegansTrends in Neurosciences, 2004
- Nature's Gift to Science (Nobel Lecture)ChemBioChem, 2003
- Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathyProceedings of the National Academy of Sciences, 2003
- IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNANature, 2002
- Abnormal Dephosphorylation Effect on NMDA Receptor Regulation in ALS Spinal CordNeurobiology of Disease, 1997